| 000 | 01815 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517131735.0 | ||
| 264 | 0 | _c20170407 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/nature20594 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLukarska, Maria | |
| 245 | 0 | 0 |
_aStructural basis of an essential interaction between influenza polymerase and Pol II CTD. _h[electronic resource] |
| 260 |
_bNature _c01 2017 |
||
| 300 |
_a117-121 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aBinding Sites _xdrug effects |
| 650 | 0 | 4 |
_aChiroptera _xvirology |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aInfluenza A virus _xenzymology |
| 650 | 0 | 4 |
_aInfluenza B virus _xenzymology |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOrthomyxoviridae _xenzymology |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPeptide Fragments _xchemistry |
| 650 | 0 | 4 |
_aPhosphoserine _xmetabolism |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 | _aProtein Domains |
| 650 | 0 | 4 | _aProtein Subunits |
| 650 | 0 | 4 |
_aRNA Polymerase II _xchemistry |
| 650 | 0 | 4 |
_aRNA-Dependent RNA Polymerase _xchemistry |
| 650 | 0 | 4 |
_aVirulence _xgenetics |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aFournier, Guillaume | |
| 700 | 1 | _aPflug, Alexander | |
| 700 | 1 | _aResa-Infante, Patricia | |
| 700 | 1 | _aReich, Stefan | |
| 700 | 1 | _aNaffakh, Nadia | |
| 700 | 1 | _aCusack, Stephen | |
| 773 | 0 |
_tNature _gvol. 541 _gno. 7635 _gp. 117-121 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature20594 _zAvailable from publisher's website |
| 999 |
_c26720148 _d26720148 |
||